Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization (HCR registry)

Seung-Jung Park

Status: Enrolling

Conditions: Percutaneous Coronary Revascularization; Coronary Artery Bypass Grafting; Coronary Artery Disease Progression; Coronary Stenosis

Treatments: Procedure: Hybrid Coronary Revascularization

Study type: Observational

Funder types: Other

Identifiers

NCT03788369

AMCCV2018-12

Details and patient eligibility

About

This study evaluated the effectiveness and safety of Hybrid Coronary Revascularization in real-world practice.

Enrollment: 200 estimated patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 20 and more
• Hybrid coronary revascularization due to multivessel coronary artery disease(must include left anterior descending artery)
• Written consent

Exclusion criteria

• Previous CABG(coronary artery bypass graft)
• Life expectancy ≤1 year

Trial design

200 participants in 1 patient group

Multivessel coronary artery disease

Description:

must include left anterior descending artery

Treatment:

Procedure: Hybrid Coronary Revascularization